Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia

Folia Neuropathologica

Volumn 42, Issue 3, 2004, Pages 141-150

  Bertrand, Ewa ^a   Lechowicz, Waldemar ^a   Szpak, Grazyna M ^a   Lewandowska, Eliza ^a   Dymecki, Jerzy ^a   Wierzba Bobrowicz, Teresa ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Degenerative changes; Dementia; Limbic system; Parkinson's disease; synuclein pathology

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; PROTEIN ANTIBODY; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYLOID NEUROPATHY; ARTICLE; AUTOPSY; BRAIN REGION; BRAIN TISSUE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; LEWY BODY; LIMBIC SYSTEM; MALE; NERVE FIBER TRANSPORT; NEURITE; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PATHOGENESIS; STATISTICAL SIGNIFICANCE;

EID: 7244238197     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Aarsland D, Tandberg E, Arsen JP, Cumings JL (1996) Frequency of dementia in Parkinson's disease. Arch Neurol, 53: 538-542.
2. Apaydin H, Ahslkog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology: later-developing dementia and loss of levodopa response. Arch Neurol, 59: 102-112.
3. Bertrand E, Lechowicz W, Lewandowska E, Szpak GM, Dymecki J, Kosno-Kruszewska E, Wierzba-Bobrowicz T (2003) Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease. Folia Neuropathol, 41: 197-207.
4. Braak H, Braak E Neuropathological staging of Alzheimer-related changes (1991). Acta Neuropathol (Berl), 82:239-259.
5. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol (Berl), 88: 493-500
6. Chuchard A, Lees AJ The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease (1997). Neurology, 49: 1570-1576.
7. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves ChL, Kotzbauer PT, Trojanowski JQ, Lee MY (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science, 300: 636-640.
8. Harding AJ and Halliday GM (1998) Simplified neuropathological diagnosis of dementia with Lewy bodies. Neuropathol Appl Neurobiol, 24: 195-201.
9. Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (Berl), 102: 355-363.
10. Harding AJ, Krill JJ, Halliday GM (2000) Practical measures to simplify the Braak tangle staging method for routine pathological screening. Acta Neuropathol (Berl), 99: 199-208.
11. Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain, 125: 2431-2445.
12. Haroutunian V, Serby M, Purohit DP, Perl DP, Marin D, Lantz M, Mohs RC, Davis KL (2000) Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological condition's. Arch Neurol, 57: 1145-1150.
13. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM-Y, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology, 54: 1916-1921.
14. Janvin C, Aarsland D, Larsen JP, Hugdahl K (2003) Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord, 15: 126-131.
15. Jellinger KA (2002a) Recent developments in the pathology of Parkinson's disease. Regular paper. J Neural transm (Suppl. 62), 347-376.
16. Jellinger KA, Seppi K, Wenning GK, Poewe W (2002b) Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm, 109: 329-339.
17. Jellinger KA, Seppi K, Wenning GK (2003) Neuropathologic changes in Parkinson's disease with late onset of dementia. Arch Neurol, 60: 452-454.
18. Kövari E, Gold G, Herrmenn FR, Canuto A, Hof PK, Bouras G, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson disease. Acta Neuropathol (Berl), 106: 83-88.
19. Matilla PM, Rinne JO, Helenius H, Röyttä M (1999) Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology. Acta Neuropathol (Berl), 98: 157-164.
20. Matilla PM, Rinne JO, Helenius H, DW Dickson, Röyttä M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (Berl) 100: 285-290
21. Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote L, Stern Y (1992) A population based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol, 49: 492-497.
22. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Report of the consortium on DLB International Workshop. Neurology, 47: 111-1124.
23. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogelm FS, Hughes JP, van Belle G, Berg L and participating CERAD neuropathologists (1991) The consortium to establish a registry for Alzheimer disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41: 479-486.
24. Rüb U, Del Tredici K, Schultz C, Ghebremedhin E, de Vos RA, Jansen Steur E, Braak H (2002) Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology. Neurobiol Aging, 23: 245-254.